APO Research
Talk to an analyst

APO RESEARCH · REPORT

Glucocorticoids

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Glucocorticoids Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025190 pages

Choose your research edition.

Industry ResearchGlucocorticoids Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Glucocorticoids Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Glucocorticoids Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glucocorticoids Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Glucocorticoids Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Glucocorticoids market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Glucocorticoids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Glucocorticoids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Glucocorticoids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Glucocorticoids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Glucocorticoids include Zhejiang Xianju Pharmaceutical Co.,Ltd, Yangzi River Pharmaceutical Group, Shandong Xinhua Pharmaceutical Company Limited, Sanofi, Novartis, Tianjin Tianyao Pharmaceuticals Co., Ltd., Pfizer, Symbiotec and Euroapi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Glucocorticoids market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Glucocorticoids and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Glucocorticoids sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Glucocorticoids market size, projected growth trends, production technologies, key applications, and end-use industries.

Glucocorticoids Segment by Company

Zhejiang Xianju Pharmaceutical Co.,Ltd

Yangzi River Pharmaceutical Group

Shandong Xinhua Pharmaceutical Company Limited

Sanofi

Novartis

Tianjin Tianyao Pharmaceuticals Co., Ltd.

Pfizer

Symbiotec

Euroapi

Cipla

Avik Pharmaceutical Limited

Aspen

Abbott Laboratories

Glucocorticoids Segment by Type

Hydrocortisone

Prednisone

Prednisolone

Cortisone

Methylprednisolone

Dexamethasone

Betamethasone

Others

Glucocorticoids Segment by Application

Vasoconstrictive

Immunosuppressive

Anti-inflammatory

Glucocorticoids Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucocorticoids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glucocorticoids and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucocorticoids.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Glucocorticoids market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Glucocorticoids manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Glucocorticoids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Glucocorticoids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Glucocorticoids Industry Trends Table 2. Glucocorticoids Industry Drivers Table 3. Glucocorticoids Industry Opportunities and Challenges Table 4. Glucocorticoids Industry Restraints Table 5. Global Glucocorticoids Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Glucocorticoids Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Glucocorticoids Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Glucocorticoids Sales Market Share by Manufacturers Table 9. Global Glucocorticoids Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Glucocorticoids Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Glucocorticoids Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Glucocorticoids Manufacturers, Product Type & Application Table 13. Global Glucocorticoids Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Glucocorticoids by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Hydrocortisone Table 17. Major Manufacturers of Prednisone Table 18. Major Manufacturers of Prednisolone Table 19. Major Manufacturers of Cortisone Table 20. Major Manufacturers of Methylprednisolone Table 21. Major Manufacturers of Dexamethasone Table 22. Major Manufacturers of Betamethasone Table 23. Major Manufacturers of Others Table 24. Global Glucocorticoids Sales by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Glucocorticoids Sales by Type (2021-2026) & (k units) Table 26. Global Glucocorticoids Sales by Type (2027-2032) & (k units) Table 27. Global Glucocorticoids Sales Market Share by Type (2021-2026) Table 28. Global Glucocorticoids Sales Market Share by Type (2027-2032) Table 29. Global Glucocorticoids Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 30. Global Glucocorticoids Revenue by Type (2021-2026) & (k units) Table 31. Global Glucocorticoids Revenue by Type (2027-2032) & (k units) Table 32. Global Glucocorticoids Revenue Market Share by Type (2021-2026) Table 33. Global Glucocorticoids Revenue Market Share by Type (2027-2032) Table 34. Major Manufacturers of Vasoconstrictive Table 35. Major Manufacturers of Immunosuppressive Table 36. Major Manufacturers of Anti-inflammatory Table 37. Global Glucocorticoids Sales by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Glucocorticoids Sales by Application (2021-2026) & (k units) Table 39. Global Glucocorticoids Sales by Application (2027-2032) & (k units) Table 40. Global Glucocorticoids Sales Market Share by Application (2021-2026) Table 41. Global Glucocorticoids Sales Market Share by Application (2027-2032) Table 42. Global Glucocorticoids Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 43. Global Glucocorticoids Revenue by Application (2021-2026) & (k units) Table 44. Global Glucocorticoids Revenue by Application (2027-2032) & (k units) Table 45. Global Glucocorticoids Revenue Market Share by Application (2021-2026) Table 46. Global Glucocorticoids Revenue Market Share by Application (2027-2032) Table 47. Global Glucocorticoids Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 48. Global Glucocorticoids Sales by Region (2021-2026) & (k units) Table 49. Global Glucocorticoids Sales Market Share by Region (2021-2026) Table 50. Global Glucocorticoids Sales Forecasted by Region (2027-2032) & (k units) Table 51. Global Glucocorticoids Sales Forecasted Market Share by Region (2027-2032) Table 52. North America Glucocorticoids Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. North America Glucocorticoids Sales by Country (2021-2026) & (k units) Table 54. North America Glucocorticoids Sales by Country (2027-2032) & (k units) Table 55. Europe Glucocorticoids Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Europe Glucocorticoids Sales by Country (2021-2026) & (k units) Table 57. Europe Glucocorticoids Sales by Country (2027-2032) & (k units) Table 58. Asia Pacific Glucocorticoids Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. Asia Pacific Glucocorticoids Sales by Country (2021-2026) & (k units) Table 60. Asia Pacific Glucocorticoids Sales by Country (2027-2032) & (k units) Table 61. South America, Middle East and Africa Glucocorticoids Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 62. South America, Middle East and Africa Glucocorticoids Sales by Country (2021-2026) & (k units) Table 63. South America, Middle East and Africa Glucocorticoids Sales by Country (2027-2032) & (k units) Table 64. Global Glucocorticoids Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 65. Global Glucocorticoids Revenue by Region (2021-2026) & (US$ Million) Table 66. Global Glucocorticoids Revenue by Region (2027-2032) & (US$ Million) Table 67. Global Glucocorticoids Revenue Market Share by Region (2021-2026) Table 68. Global Glucocorticoids Revenue Market Share by Region (2027-2032) Table 69. Zhejiang Xianju Pharmaceutical Co.,Ltd Company Information Table 70. Zhejiang Xianju Pharmaceutical Co.,Ltd Business Overview Table 71. Zhejiang Xianju Pharmaceutical Co.,Ltd Glucocorticoids Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Zhejiang Xianju Pharmaceutical Co.,Ltd Glucocorticoids Product Portfolio Table 73. Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Development Table 74. Yangzi River Pharmaceutical Group Company Information Table 75. Yangzi River Pharmaceutical Group Business Overview Table 76. Yangzi River Pharmaceutical Group Glucocorticoids Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Yangzi River Pharmaceutical Group Glucocorticoids Product Portfolio Table 78. Yangzi River Pharmaceutical Group Recent Development Table 79. Shandong Xinhua Pharmaceutical Company Limited Company Information Table 80. Shandong Xinhua Pharmaceutical Company Limited Business Overview Table 81. Shandong Xinhua Pharmaceutical Company Limited Glucocorticoids Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Shandong Xinhua Pharmaceutical Company Limited Glucocorticoids Product Portfolio Table 83. Shandong Xinhua Pharmaceutical Company Limited Recent Development Table 84. Sanofi Company Information Table 85. Sanofi Business Overview Table 86. Sanofi Glucocorticoids Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Sanofi Glucocorticoids Product Portfolio Table 88. Sanofi Recent Development Table 89. Novartis Company Information Table 90. Novartis Business Overview Table 91. Novartis Glucocorticoids Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Novartis Glucocorticoids Product Portfolio Table 93. Novartis Recent Development Table 94. Tianjin Tianyao Pharmaceuticals Co., Ltd. Company Information Table 95. Tianjin Tianyao Pharmaceuticals Co., Ltd. Business Overview Table 96. Tianjin Tianyao Pharmaceuticals Co., Ltd. Glucocorticoids Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Tianjin Tianyao Pharmaceuticals Co., Ltd. Glucocorticoids Product Portfolio Table 98. Tianjin Tianyao Pharmaceuticals Co., Ltd. Recent Development Table 99. Pfizer Company Information Table 100. Pfizer Business Overview Table 101. Pfizer Glucocorticoids Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Pfizer Glucocorticoids Product Portfolio Table 103. Pfizer Recent Development Table 104. Symbiotec Company Information Table 105. Symbiotec Business Overview Table 106. Symbiotec Glucocorticoids Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Symbiotec Glucocorticoids Product Portfolio Table 108. Symbiotec Recent Development Table 109. Euroapi Company Information Table 110. Euroapi Business Overview Table 111. Euroapi Glucocorticoids Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Euroapi Glucocorticoids Product Portfolio Table 113. Euroapi Recent Development Table 114. Cipla Company Information Table 115. Cipla Business Overview Table 116. Cipla Glucocorticoids Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Cipla Glucocorticoids Product Portfolio Table 118. Cipla Recent Development Table 119. Avik Pharmaceutical Limited Company Information Table 120. Avik Pharmaceutical Limited Business Overview Table 121. Avik Pharmaceutical Limited Glucocorticoids Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Avik Pharmaceutical Limited Glucocorticoids Product Portfolio Table 123. Avik Pharmaceutical Limited Recent Development Table 124. Aspen Company Information Table 125. Aspen Business Overview Table 126. Aspen Glucocorticoids Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Aspen Glucocorticoids Product Portfolio Table 128. Aspen Recent Development Table 129. Abbott Laboratories Company Information Table 130. Abbott Laboratories Business Overview Table 131. Abbott Laboratories Glucocorticoids Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Abbott Laboratories Glucocorticoids Product Portfolio Table 133. Abbott Laboratories Recent Development Table 134. Key Raw Materials Table 135. Raw Materials Key Suppliers Table 136. Glucocorticoids Distributors List Table 137. Glucocorticoids Customers List Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Glucocorticoids Product Image Figure 2. Global Glucocorticoids Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glucocorticoids Market Size (2021-2032) & (US$ Million) Figure 4. Global Glucocorticoids Sales (2021-2032) & (k units) Figure 5. Global Glucocorticoids Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Glucocorticoids Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Hydrocortisone Image Figure 9. Prednisone Image Figure 10. Prednisolone Image Figure 11. Cortisone Image Figure 12. Methylprednisolone Image Figure 13. Dexamethasone Image Figure 14. Betamethasone Image Figure 15. Others Image Figure 16. Global Glucocorticoids Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 17. Global Glucocorticoids Sales Market Share 2021 VS 2025 VS 2032 Figure 18. Global Glucocorticoids Sales Market Share by Type (2021-2032) Figure 19. Global Glucocorticoids Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Glucocorticoids Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Glucocorticoids Revenue Market Share by Type (2021-2032) Figure 22. Vasoconstrictive Image Figure 23. Immunosuppressive Image Figure 24. Anti-inflammatory Image Figure 25. Global Glucocorticoids Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Glucocorticoids Sales Market Share 2021 VS 2025 VS 2032 Figure 27. Global Glucocorticoids Sales Market Share by Application (2021-2032) Figure 28. Global Glucocorticoids Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 29. Global Glucocorticoids Revenue Market Share 2021 VS 2025 VS 2032 Figure 30. Global Glucocorticoids Revenue Market Share by Application (2021-2032) Figure 31. North America Glucocorticoids Sales and Growth Rate (2021-2032) & (k units) Figure 32. North America Glucocorticoids Sales Market Share by Country (2021-2032) Figure 33. U.S. Glucocorticoids Sales and Growth Rate (2021-2032) & (k units) Figure 34. Canada Glucocorticoids Sales and Growth Rate (2021-2032) & (k units) Figure 35. Mexico Glucocorticoids Sales and Growth Rate (2021-2032) & (k units) Figure 36. Europe Glucocorticoids Sales and Growth Rate (2021-2032) & (k units) Figure 37. Europe Glucocorticoids Sales Market Share by Country (2021-2032) Figure 38. Germany Glucocorticoids Sales and Growth Rate (2021-2032) & (k units) Figure 39. France Glucocorticoids Sales and Growth Rate (2021-2032) & (k units) Figure 40. U.K. Glucocorticoids Sales and Growth Rate (2021-2032) & (k units) Figure 41. Italy Glucocorticoids Sales and Growth Rate (2021-2032) & (k units) Figure 42. Netherlands Glucocorticoids Sales and Growth Rate (2021-2032) & (k units) Figure 43. Asia Pacific Glucocorticoids Sales and Growth Rate (2021-2032) & (k units) Figure 44. Asia Pacific Glucocorticoids Sales Market Share by Country (2021-2032) Figure 45. China Glucocorticoids Sales and Growth Rate (2021-2032) & (k units) Figure 46. Japan Glucocorticoids Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Korea Glucocorticoids Sales and Growth Rate (2021-2032) & (k units) Figure 48. Southeast Asia Glucocorticoids Sales and Growth Rate (2021-2032) & (k units) Figure 49. India Glucocorticoids Sales and Growth Rate (2021-2032) & (k units) Figure 50. Australia Glucocorticoids Sales and Growth Rate (2021-2032) & (k units) Figure 51. South America, Middle East and Africa Glucocorticoids Sales and Growth Rate (2021-2032) & (k units) Figure 52. South America, Middle East and Africa Glucocorticoids Sales Market Share by Country (2021-2032) Figure 53. Brazil Glucocorticoids Sales and Growth Rate (2021-2032) & (k units) Figure 54. South Africa Glucocorticoids Sales and Growth Rate (2021-2032) & (k units) Figure 55. Saudi Arabia Glucocorticoids Sales and Growth Rate (2021-2032) & (k units) Figure 56. Turkey Glucocorticoids Sales and Growth Rate (2021-2032) & (k units) Figure 57. Argentina Glucocorticoids Sales and Growth Rate (2021-2032) & (k units) Figure 58. UAE Glucocorticoids Sales and Growth Rate (2021-2032) & (k units) Figure 59. Egypt Glucocorticoids Sales and Growth Rate (2021-2032) & (k units) Figure 60. Chile Glucocorticoids Sales and Growth Rate (2021-2032) & (k units) Figure 61. Global Glucocorticoids Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Global Glucocorticoids Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 63. North America Glucocorticoids Revenue (2021-2032) & (US$ Million) Figure 64. North America Glucocorticoids Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Europe Glucocorticoids Revenue (2021-2032) & (US$ Million) Figure 66. Europe Glucocorticoids Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific Glucocorticoids Revenue (2021-2032) & (US$ Million) Figure 68. Asia-Pacific Glucocorticoids Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. South America, Middle East and Africa Glucocorticoids Revenue (2021-2032) & (US$ Million) Figure 70. South America, Middle East and Africa Glucocorticoids Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 71. Glucocorticoids Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Glucocorticoids Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Hydrocortisone
  • Prednisone
  • Prednisolone
  • Cortisone
  • Methylprednisolone
  • Dexamethasone
  • Betamethasone
  • Others
Applications
  • Vasoconstrictive
  • Immunosuppressive
  • Anti-inflammatory
Companies covered
  • Zhejiang Xianju Pharmaceutical Co.,Ltd
  • Yangzi River Pharmaceutical Group
  • Shandong Xinhua Pharmaceutical Company Limited
  • Sanofi
  • Novartis
  • Tianjin Tianyao Pharmaceuticals Co., Ltd.
  • Pfizer
  • Symbiotec
  • Euroapi
  • Cipla
  • Avik Pharmaceutical Limited
  • Aspen
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Glucocorticoids Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Glucocorticoids Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Glucocorticoids Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Glucocorticoids Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Glucocorticoids Market Dynamics
  1. 2.1 Glucocorticoids Industry Trends
  2. 2.2 Glucocorticoids Industry Drivers
  3. 2.3 Glucocorticoids Industry Opportunities and Challenges
  4. 2.4 Glucocorticoids Industry Restraints
3 Glucocorticoids Market by Manufacturers
  1. 3.1 Global Glucocorticoids Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Glucocorticoids Sales by Manufacturers (2021-2026)
  3. 3.3 Global Glucocorticoids Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Glucocorticoids Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Glucocorticoids Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Glucocorticoids Manufacturers, Product Type & Application
  7. 3.7 Global Glucocorticoids Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Glucocorticoids Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Glucocorticoids Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Glucocorticoids Tier 1, Tier 2, and Tier 3
4 Glucocorticoids Market by Type
  1. 4.1 Glucocorticoids Type Introduction
  2. 4.1.1 Hydrocortisone
  3. 4.1.2 Prednisone
  4. 4.1.3 Prednisolone
  5. 4.1.4 Cortisone
  6. 4.1.5 Methylprednisolone
  7. 4.1.6 Dexamethasone
  8. 4.1.7 Betamethasone
  9. 4.1.8 Others
  10. 4.2 Global Glucocorticoids Sales by Type
  11. 4.2.1 Global Glucocorticoids Sales by Type (2021 VS 2025 VS 2032)
  12. 4.2.2 Global Glucocorticoids Sales by Type (2021-2032)
  13. 4.2.3 Global Glucocorticoids Sales Market Share by Type (2021-2032)
  14. 4.3 Global Glucocorticoids Revenue by Type
  15. 4.3.1 Global Glucocorticoids Revenue by Type (2021 VS 2025 VS 2032)
  16. 4.3.2 Global Glucocorticoids Revenue by Type (2021-2032)
  17. 4.3.3 Global Glucocorticoids Revenue Market Share by Type (2021-2032)
5 Glucocorticoids Market by Application
  1. 5.1 Glucocorticoids Application Introduction
  2. 5.1.1 Vasoconstrictive
  3. 5.1.2 Immunosuppressive
  4. 5.1.3 Anti-inflammatory
  5. 5.2 Global Glucocorticoids Sales by Application
  6. 5.2.1 Global Glucocorticoids Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Glucocorticoids Sales by Application (2021-2032)
  8. 5.2.3 Global Glucocorticoids Sales Market Share by Application (2021-2032)
  9. 5.3 Global Glucocorticoids Revenue by Application
  10. 5.3.1 Global Glucocorticoids Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Glucocorticoids Revenue by Application (2021-2032)
  12. 5.3.3 Global Glucocorticoids Revenue Market Share by Application (2021-2032)
6 Global Glucocorticoids Sales by Region
  1. 6.1 Global Glucocorticoids Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Glucocorticoids Sales by Region (2021-2032)
  3. 6.2.1 Global Glucocorticoids Sales by Region (2021-2026)
  4. 6.2.2 Global Glucocorticoids Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Glucocorticoids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Glucocorticoids Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Glucocorticoids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Glucocorticoids Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Glucocorticoids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Glucocorticoids Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Glucocorticoids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Glucocorticoids Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Glucocorticoids Revenue by Region
  1. 7.1 Global Glucocorticoids Revenue by Region
  2. 7.1.1 Global Glucocorticoids Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Glucocorticoids Revenue by Region (2021-2026)
  4. 7.1.3 Global Glucocorticoids Revenue by Region (2027-2032)
  5. 7.1.4 Global Glucocorticoids Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Glucocorticoids Revenue (2021-2032)
  8. 7.2.2 North America Glucocorticoids Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Glucocorticoids Revenue (2021-2032)
  11. 7.3.2 Europe Glucocorticoids Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Glucocorticoids Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Glucocorticoids Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Glucocorticoids Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Glucocorticoids Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Xianju Pharmaceutical Co.,Ltd
  2. 8.1.1 Zhejiang Xianju Pharmaceutical Co.,Ltd Company Information
  3. 8.1.2 Zhejiang Xianju Pharmaceutical Co.,Ltd Business Overview
  4. 8.1.3 Zhejiang Xianju Pharmaceutical Co.,Ltd Glucocorticoids Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Xianju Pharmaceutical Co.,Ltd Glucocorticoids Product Portfolio
  6. 8.1.5 Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Developments
  7. 8.2 Yangzi River Pharmaceutical Group
  8. 8.2.1 Yangzi River Pharmaceutical Group Company Information
  9. 8.2.2 Yangzi River Pharmaceutical Group Business Overview
  10. 8.2.3 Yangzi River Pharmaceutical Group Glucocorticoids Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Yangzi River Pharmaceutical Group Glucocorticoids Product Portfolio
  12. 8.2.5 Yangzi River Pharmaceutical Group Recent Developments
  13. 8.3 Shandong Xinhua Pharmaceutical Company Limited
  14. 8.3.1 Shandong Xinhua Pharmaceutical Company Limited Company Information
  15. 8.3.2 Shandong Xinhua Pharmaceutical Company Limited Business Overview
  16. 8.3.3 Shandong Xinhua Pharmaceutical Company Limited Glucocorticoids Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shandong Xinhua Pharmaceutical Company Limited Glucocorticoids Product Portfolio
  18. 8.3.5 Shandong Xinhua Pharmaceutical Company Limited Recent Developments
  19. 8.4 Sanofi
  20. 8.4.1 Sanofi Company Information
  21. 8.4.2 Sanofi Business Overview
  22. 8.4.3 Sanofi Glucocorticoids Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sanofi Glucocorticoids Product Portfolio
  24. 8.4.5 Sanofi Recent Developments
  25. 8.5 Novartis
  26. 8.5.1 Novartis Company Information
  27. 8.5.2 Novartis Business Overview
  28. 8.5.3 Novartis Glucocorticoids Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Novartis Glucocorticoids Product Portfolio
  30. 8.5.5 Novartis Recent Developments
  31. 8.6 Tianjin Tianyao Pharmaceuticals Co., Ltd.
  32. 8.6.1 Tianjin Tianyao Pharmaceuticals Co., Ltd. Company Information
  33. 8.6.2 Tianjin Tianyao Pharmaceuticals Co., Ltd. Business Overview
  34. 8.6.3 Tianjin Tianyao Pharmaceuticals Co., Ltd. Glucocorticoids Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Tianjin Tianyao Pharmaceuticals Co., Ltd. Glucocorticoids Product Portfolio
  36. 8.6.5 Tianjin Tianyao Pharmaceuticals Co., Ltd. Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer Glucocorticoids Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Glucocorticoids Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 Symbiotec
  44. 8.8.1 Symbiotec Company Information
  45. 8.8.2 Symbiotec Business Overview
  46. 8.8.3 Symbiotec Glucocorticoids Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Symbiotec Glucocorticoids Product Portfolio
  48. 8.8.5 Symbiotec Recent Developments
  49. 8.9 Euroapi
  50. 8.9.1 Euroapi Company Information
  51. 8.9.2 Euroapi Business Overview
  52. 8.9.3 Euroapi Glucocorticoids Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Euroapi Glucocorticoids Product Portfolio
  54. 8.9.5 Euroapi Recent Developments
  55. 8.10 Cipla
  56. 8.10.1 Cipla Company Information
  57. 8.10.2 Cipla Business Overview
  58. 8.10.3 Cipla Glucocorticoids Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Cipla Glucocorticoids Product Portfolio
  60. 8.10.5 Cipla Recent Developments
  61. 8.11 Avik Pharmaceutical Limited
  62. 8.11.1 Avik Pharmaceutical Limited Company Information
  63. 8.11.2 Avik Pharmaceutical Limited Business Overview
  64. 8.11.3 Avik Pharmaceutical Limited Glucocorticoids Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Avik Pharmaceutical Limited Glucocorticoids Product Portfolio
  66. 8.11.5 Avik Pharmaceutical Limited Recent Developments
  67. 8.12 Aspen
  68. 8.12.1 Aspen Company Information
  69. 8.12.2 Aspen Business Overview
  70. 8.12.3 Aspen Glucocorticoids Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Aspen Glucocorticoids Product Portfolio
  72. 8.12.5 Aspen Recent Developments
  73. 8.13 Abbott Laboratories
  74. 8.13.1 Abbott Laboratories Company Information
  75. 8.13.2 Abbott Laboratories Business Overview
  76. 8.13.3 Abbott Laboratories Glucocorticoids Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Abbott Laboratories Glucocorticoids Product Portfolio
  78. 8.13.5 Abbott Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Glucocorticoids Value Chain Analysis
  2. 9.1.1 Glucocorticoids Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Glucocorticoids Production Mode & Process
  6. 9.2 Glucocorticoids Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Glucocorticoids Distributors
  9. 9.2.3 Glucocorticoids Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst